Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › MI › DEARBORN › ALI HAZIMEH PLLC

ALI HAZIMEH PLLC

NPI: 1437796216 · DEARBORN, MI 48126 · Home Health Agency · NPI assigned 11/29/2019

$5.83M
Total Medicaid Paid
167,944
Total Claims
148,942
Beneficiaries
135
Codes Billed
2020-04
First Month
2024-12
Last Month

Provider Details

Authorized OfficialHAZIMEH, ALI (OWNER)
NPI Enumeration Date11/29/2019

Related Entities

Other providers sharing the same authorized official: HAZIMEH, ALI

ProviderCityStateTotal Paid
HAZIMEH PRIMARY CARE PLLC DEARBORN MI $498K
INPATIENT CARE SPECIALISTS PLLC DEARBORN MI $214K
HMC URGENT CARE GROSS POINTE PLLC DETROIT MI $31K
HMC URGENT CARE WAYNE PLLC DEARBORN HEIGHTS MI $3K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2020 8,598 $310K
2021 31,959 $1.40M
2022 54,235 $1.73M
2023 36,912 $1.21M
2024 36,240 $1.18M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 29,066 25,121 $1.79M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 19,858 17,161 $1.54M
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 14,558 14,232 $997K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 20,074 17,267 $571K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 1,265 1,230 $118K
99215 Prolong outpt/office vis 998 938 $104K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 3,357 3,047 $103K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 2,240 2,078 $97K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 11,234 7,925 $71K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 971 828 $68K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 2,831 2,382 $52K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 726 718 $42K
71046 Radiologic examination, chest; 2 views 1,653 1,559 $27K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 2,245 2,179 $19K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 255 244 $19K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 261 246 $16K
36415 Collection of venous blood by venipuncture 5,201 4,861 $16K
S9083 Global fee urgent care centers 316 272 $13K
97597 289 222 $11K
81025 1,866 1,751 $9K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1,778 1,521 $9K
99205 Prolong outpt/office vis 71 70 $8K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 313 294 $8K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 848 765 $7K
93000 1,065 1,030 $7K
81002 3,514 3,303 $7K
90460 Immunization administration through 18 years of age via any route, first or only component 161 158 $7K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 847 679 $6K
99001 7,637 7,168 $6K
81001 3,849 3,512 $5K
20552 179 160 $5K
99201 132 132 $4K
72100 189 178 $4K
29540 270 252 $3K
99232 Subsequent hospital care, per day, moderate complexity 66 27 $3K
J1885 Injection, ketorolac tromethamine, per 15 mg 4,007 3,617 $3K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 735 690 $3K
86580 583 533 $3K
90472 Immunization administration, each additional vaccine (list separately) 99 97 $3K
99000 3,796 3,597 $3K
87631 767 681 $3K
73560 186 175 $2K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 3,392 3,135 $2K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 136 124 $2K
99401 120 117 $2K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 112 97 $2K
73120 126 124 $2K
80305 229 216 $2K
99473 230 220 $1K
86328 57 53 $1K
73630 75 70 $1K
73130 75 68 $1K
87428 38 34 $1K
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 1,160 994 $1K
80306 158 140 $1K
J0696 Injection, ceftriaxone sodium, per 250 mg 1,307 1,192 $1K
83037 186 179 $782.28
57410 59 48 $744.86
90686 93 90 $713.32
73620 67 67 $700.54
96361 Intravenous infusion, hydration; each additional hour 110 108 $676.92
0001A 35 32 $605.60
29280 66 54 $550.31
29530 41 39 $512.36
G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination 26 26 $482.60
73600 31 28 $471.66
82962 249 212 $468.64
73020 49 45 $460.28
69210 14 14 $439.15
83036 Hemoglobin; glycosylated (A1C) 125 113 $435.60
96127 173 163 $431.25
87070 176 154 $348.94
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 70 70 $345.30
74019 15 15 $266.15
99406 68 64 $251.42
90715 77 77 $238.17
29130 12 12 $229.02
90658 12 12 $191.78
29260 13 12 $176.91
82948 107 104 $151.21
99459 14 14 $148.57
87807 15 14 $131.29
73030 12 12 $125.26
J7030 Infusion, normal saline solution , 1000 cc 186 169 $118.18
36410 1,360 1,215 $105.73
15853 12 12 $88.35
99407 14 13 $87.35
J2405 Injection, ondansetron hydrochloride, per 1 mg 383 357 $78.58
99173 207 205 $75.00
96375 Therapeutic injection; each additional sequential IV push 14 12 $74.48
90653 16 14 $59.53
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 484 413 $50.05
A7003 Administration set, with small volume nonfiltered pneumatic nebulizer, disposable 91 86 $48.49
96160 19 19 $30.02
86317 13 12 $24.82
90656 12 12 $22.35
81000 69 67 $13.32
J1020 Injection, methylprednisolone acetate, 20 mg 16 15 $11.00
94760 946 757 $8.40
81005 13 12 $7.16
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 53 49 $2.32
3077F 1,097 1,017 $1.84
3080F 898 834 $1.43
3079F 249 241 $0.39
3075F 263 258 $0.35
3351F 66 65 $0.11
3078F 81 71 $0.05
3051F 14 12 $0.05
G8483 Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) 272 266 $0.02
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 15 15 $0.01
4004F 186 178 $0.01
G0447 Face-to-face behavioral counseling for obesity, 15 minutes 64 61 $0.00
3044F 85 73 $0.00
90651 57 57 $0.00
H0033 Oral medication administration, direct observation 32 31 $0.00
90619 29 28 $0.00
A4253 Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips 16 16 $0.00
3074F 44 38 $0.00
90716 27 26 $0.00
1111F 21 20 $0.00
G8510 Screening for depression is documented as negative, a follow-up plan is not required 15 14 $0.00
S9470 Nutritional counseling, dietitian visit 220 212 $0.00
G8712 Antibiotic not prescribed or dispensed 169 109 $0.00
S3005 Performance measurement, evaluation of patient self assessment, depression 43 41 $0.00
90461 108 107 $0.00
99080 143 135 $0.00
90707 26 25 $0.00
G0444 Annual depression screening, 5 to 15 minutes 152 136 $0.00
J8499 Prescription drug, oral, non chemotherapeutic, nos 66 65 $0.00
90633 19 19 $0.00
90713 17 17 $0.00
97602 14 13 $0.00
G8417 Bmi is documented above normal parameters and a follow-up plan is documented 18 17 $0.00
90710 12 12 $0.00
90700 12 12 $0.00